The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics
The baseline characteristics of the study subjects are: age 59+/-8 years, duration of diabetes 15+/-9 years, height 168+/-11 cm (5 ft 6 in), weight 87+/-19 kg (192 lb), body mas...